Along this speculative line, previous studies showed that tau-related degeneration within neuromodulatory subcortical systems can be found in AD patients at earlier disease stages, even before observable memory deficits and volumetric cortical atrophy (for a recent review, see [39]). This evidence concerns the gene MAPT and Alzheimer disease.